To cite this paper use one of the standards below:
Shiitake (Lentinula edodes) is a valuable source of bioactive compounds with nutraceutical benefits for human health. This study aimed to develop a food bioproduct, Shiitake mycelium, and mushrooms, and characterize them as potential regenerative agents. The bioproduct was developed through solid-state fermentation of Bactris gasipaes waste (peach palm shells) supplemented with sorghum flour (20%), by L. edodes. Shiitake mushrooms were cultivated in an axenic system (same substrate) and L. edodes mycelium was cultivated in a submerged system (synthetic media). Bioactive compounds were analyzed: β-glucans (enzymatic colorimetric method), total phenolic (Folin-Ciocalteu method), and hydrophilic/lipophilic (gas chromatography-mass spectroscopy). Cytotoxicity tests (MTT assay) were performed on 3T3 fibroblast and Human dermal fibroblast cells at different concentrations (0.1, 0.5, 1, 5, 12.5, and 25 mg/ml). The bioproduct, mushrooms, and mycelium showed high β-glucan content (9.44, 29.53, and 22.84 g/100g, respectively), linked to healing, tissue regeneration, collagen synthesis, anti-inflammatory effects, and immune modulation. Significant levels of other compounds associated with tissue regeneration and antioxidant properties were also found in the bioproduct and mushrooms (GC-MS), such as phenolic compounds (6.33 and 5.56 mg/g, respectively), glucosamine, proline, phenylalanine, mannitol, trehalose, octadecadienoic-acid-methyl-ester, tyrosine, and erythritol. Cytotoxicity results showed that the lowest the concentration of mushrooms and mycelium, the highest the cell viability, with a maximum (0.1 mg/ml) of 69.23% and 64.08% for 3T3 cells and 100.28% and 94.56% for Human dermal cell. The bioproduct was non-toxic at all concentrations tested, with cell viability exceeding 70%, and significantly stimulated cell proliferation for 3T3 (73.60%-702.51%) and Human dermal cells (98.63%-800.52%). Results indicate that the fungus synthesizes compounds with the potential to be explored for new drugs and cosmetics research. This study highlighted the sustainable reuse of agro-industrial waste to produce a bioproduct for human health while supporting the circular bioeconomy and helping mitigate environmental impacts associated with waste disposal.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper